JULIÁN
SANZ ORTEGA
Profesor titular de universidad
Publicaciones (46) Publicaciones de JULIÁN SANZ ORTEGA
2023
-
A slightly different polyp: melanoma metastasis diagnosed by colonoscopy
Revista espanola de enfermedades digestivas, Vol. 115, Núm. 6, pp. 343-344
-
Focal Therapy of Prostate Cancer Index Lesion With Irreversible Electroporation. A Prospective Study With a Median Follow-up of 3 Years
The Journal of urology, Vol. 209, Núm. 1, pp. 261-270
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Practical aspects of PD-L1 assessment in the treatment of urothelial carcinoma: Consensus of the uropathology group of the SEAP
Revista Espanola de Patologia, Vol. 56, Núm. 4, pp. 261-270
-
Reply by Authors
The Journal of urology, Vol. 209, Núm. 1, pp. 270
2022
-
miRNome profiling of lung cancer metastases revealed a key role for miRNA-PD-L1 axis in the modulation of chemotherapy response
Journal of Hematology and Oncology, Vol. 15, Núm. 1
2019
-
Prostate pathology recommendations from the Uropathology working group of the Spanish Society of Pathology
Revista Espanola de Patologia, Vol. 52, Núm. 3, pp. 167-177
2018
-
Aligning digital CD8
+
scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma
Histopathology, Vol. 72, Núm. 2, pp. 270-284
-
Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer
Oral Oncology
-
Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment
Histology and histopathology, Vol. 33, Núm. 11, pp. 1167-1180
2017
-
S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison with Novel and Traditional Urothelial Immunohistochemical Markers
Advances in Anatomic Pathology, Vol. 24, Núm. 3, pp. 151-160
2015
-
A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer
Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338
-
Ewing-like sarcoma with CIC-DUX4 gene fusion in a patient with neurofibromatosis type 1. A hitherto unreported association
Pathology Research and Practice, Vol. 211, Núm. 11, pp. 877-882
2013
-
Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome
American Journal of Surgical Pathology, Vol. 37, Núm. 1, pp. 74-80
2012
-
Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior
BMC Cancer, Vol. 12
-
Serrated polyps of the colon: How reproducible is their classification?
Virchows Archiv, Vol. 461, Núm. 5, pp. 495-504
-
Study of KRAS new predictive marker in a clinical laboratory
Clinical and Translational Oncology, Vol. 14, Núm. 12, pp. 937-942
2010
-
Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II
Histology and Histopathology, Vol. 25, Núm. 3, pp. 341-349
2009
-
Cáncer de riñón hereditario
Actas Urologicas Espanolas, Vol. 33, Núm. 2, pp. 127-133
2007
-
17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer
Histology and Histopathology, Vol. 22, Núm. 4-6, pp. 541-545